Psychedelics for Alcoholism

Investor Deep Dive

February 23, 2022

Market Analyst Marissa Wright Discusses the Psychedelics Market with a Focus on Alcohol Use Disorder Psychedelic Treatments


Marissa Wright, MBA

Independent Business Analyst

Marissa Wright is an independent consultant on business strategy, market analysis, and new market entry for global firms, based in Vancouver, Canada. She has 40 years of experience as an entrepreneur and developing new business in North America across a wide range of industries and is an active member of Keiretsu Forum, the world’s largest early-stage angel investor network.

Adi Zuloff-Shani, PhD

Clearmind's Chief Executive Officer

Dr. Adi Zuloff-Shani is a biomedical research and development executive with over 20 years of strategic and operational leadership in the healthcare industry, and a deep understanding of therapeutics development in heavily regulated environments.

Adjunct Prof. Mark Haden

Clearmind's VP of Business Development

Previously the Executive Director of MAPS Canada for 10 years, Mark is an adjunct professor at the University of British Columbia's School of Population and Public Health, and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counselling, supervisory and management positions for 28 years.


Shannon Smadella

Wellness Personality & Podcast Host, Executive Consultant, Former Miss Canada

Shannon has interviewed some of the most prominent leaders, scientists, doctors and thinkers in the psychedelic space. She was the host/co-organizer of Seasons 1 & 2 of "Examining The Psychedelic Renaissance" with MAPS Canada and the Inaugural World Psychedelics Day [6.20] She has worked in business for the past 20 years, raising millions for various charities & organizations, including those in psychedelics.